ADD/ADHD



Attention Deficit Hyperactivity Disorder (ADHD) Prediction of Treatment Response


Condition:   Attention Deficit Hyperactivity Disorder
Interventions:   Drug: Methylphenidate LA (Ritalin);   Drug: Mixed Amphetamine Salts XR (Adderall)
Sponsors:   Massachusetts General Hospital;   Massachusetts Institute of Technology
Not yet recruiting - verified May 2017


Methylphenidate in Adults With Attention Deficit/Hyperactivity Disorder


Condition:   Attention Deficit Disorder With Hyperactivity
Intervention:   Drug: Immediate-release Methylphenidate
Sponsors:   Hospital de Clinicas de Porto Alegre;   Federal University of Rio Grande do Sul;   Conselho Nacional de Desenvolvimento Científico e Tecnológico;   Coordination for the Improvement of Higher Education Personnel
Recruiting - verified October 2016


Cognitive Behavior Group Therapy in Adolescents With Attention Deficit Hyperactivity Disorder


Condition:   Attention Deficit Disorder With Hyperactivity
Interventions:   Behavioral: cognitive behavior group therapy;   Other: Treatment as usual
Sponsors:   St. Olavs Hospital;   Norwegian University of Science and Technology
Recruiting - verified January 2017


Group-based Cognitive-behavioral Therapy for Adults With Attention-deficit/Hyperactivity Disorder Inattentive-type


Condition:   Attention Deficit Disorder With Hyperactivity
Intervention:   Behavioral: Cognitive-behavioral therapy
Sponsor:   Karolinska Institutet
Recruiting - verified August 2016


Mazindol Controlled Release in Adults With Attention Deficit Hyperactivity Disorder (ADHD)


Condition:   Attention Deficit Disorder With Hyperactivity
Intervention:   Drug: mazindol
Sponsor:   NLS-1 Pharma Inc.
Completed - verified April 2017


Effectiveness of a Personalized Neurofeedback Training Device (ADHD@Home) in Attention-Deficit/Hyperactivity Disorder


Condition:   Attention Deficit-Hyperactivity Disorder
Interventions:   Device: Neurofeedback NFT;   Drug: Methylphenidate MPH
Sponsors:   Mensia Technologies SA;   European Union H2020 SME Instrument
Recruiting - verified April 2017


A Study to Evaluate the Efficacy and Safety of Dasotraline in Children 6 to 12 Years of Age With Attention-Deficit Hyperactivity Disorder (ADHD) in a Simulated Classroom Setting.


Condition:   Attention-Deficit Hyperactivity Disorder (ADHD)
Interventions:   Drug: dasotraline 4mg;   Other: Placebo
Sponsor:   Sunovion
Completed - verified March 2017


Rhodiola Rosea in Adults With Attention Deficit/Hyperactivity Disorder


Condition:   Attention Deficit/Hyperactivity Disorder
Interventions:   Drug: Rhodiola;   Drug: Placebo
Sponsor:   Hospital de Clinicas de Porto Alegre
Recruiting - verified May 2016


Effects of 800mg of Rhodiola Rosea in Attention in Adults With Attention-Deficit/Hyperactivity Disorder


Condition:   Attention Deficit Hyperactivity Disorder
Interventions:   Drug: Rhodiola;   Drug: Placebo
Sponsor:   Hospital de Clinicas de Porto Alegre
Recruiting - verified May 2016


Brain Training in Children With/At-risk for Attention-Deficit/Hyperactivity Disorder and Executive Function Impairment


Condition:   Attention Deficit Hyperactivity Disorder
Interventions:   Behavioral: Brain Training (Active);   Behavioral: Brain Training (Passive);   Behavioral: Brain Training (Active or Passive)
Sponsor:   Stanford University
Recruiting - verified October 2016


Cognitive Training in Children With Attention Deficit Hyperactivity Disorder (ADHD)


Condition:   Attention Deficit Hyperactivity Disorder (ADHD)
Interventions:   Behavioral: Cogmed;   Behavioral: Presco
Sponsor:   Assistance Publique - Hôpitaux de Paris
Recruiting - verified August 2016


Safety and Efficacy Study of Centanafadine Sustained-Release (CTN SR) in Adults With Attention-Deficit Hyperactivity Disorder (ADHD)


Condition:   Attention-Deficit Hyperactivity Disorder
Interventions:   Drug: CTN SR;   Drug: Placebo
Sponsor:   Neurovance, Inc.
Completed - verified June 2016


The Characteristics of Prepulse Inhibition in Children and Adolescents Suffering From Attention Deficit Disorder


Condition:   Attention Deficit Disorder
Interventions:   Device: SR-HLAB EMG;   Drug: Methylphenidate
Sponsors:   HaEmek Medical Center, Israel;   Technion, Israel Institute of Technology
Active, not recruiting - verified August 2016


Attention Deficit/Hyperactivity Disorder Internet Survey Study in a College Student Population


Condition:   Attention Deficit Hyperactivity Disorder
Intervention:  
Sponsor:   Wake Forest University Health Sciences
Completed - verified December 2015


Efficacy of Cognitive Behavioral Therapy in Treatment of Adults With Attention Deficit Hyperactivity Disorder


Condition:   Attention Deficit Hyperactivity Disorder
Interventions:   Drug: methylphenidate or amphetamine product;   Behavioral: Cognitive behavioral therapy
Sponsor:   Lily Hechtman
Active, not recruiting - verified March 2017


Safety, Tolerability, and Pharmacokinetics of Multiple Rising Doses of TAK-137 in Adults With Attention-Deficit/Hyperactivity Disorder.


Condition:   Attention-Deficit/Hyperactivity Disorder
Interventions:   Drug: TAK-137;   Drug: TAK-137 Placebo
Sponsor:   Takeda
Terminated - verified June 2016


An Open-Label Study of Naltrexone in Adults With Attention Deficit Hyperactivity Disorder.


Condition:   Attention Deficit Hyperactivity Disorder
Intervention:   Drug: Naltrexone
Sponsor:   Massachusetts General Hospital
Completed - verified November 2016


Attention Deficit Hyperactivity Disorder Drugs Use Chronic Effects


Condition:   Attention Deficit Hyperactivity Disorder (ADHD)
Intervention:  
Sponsors:   NHS Tayside;   Zentralinstitut für Seelische Gesundheit Mannheim;   Universita degli Studi di Cagliari;   Vadaskert Child and Adolescent Psychiatric Hospital
Completed - verified September 2016


Comparative Effectiveness Research for Two Medical Home Models for Attention Deficit Hyperactivity Disorder


Condition:   Attention Deficit/Hyperactivity Disorder
Interventions:   Behavioral: Collaborative Care Plus;   Behavioral: Traditional Collaborative Care
Sponsors:   Boston Medical Center;   Codman Square Health Center;   Dorchester House Health Center
Completed - verified October 2016


International Study to Predict Optimised Treatment in Attention Deficit/Hyperactivity Disorder


Condition:   Attention Deficit/Hyperactivity Disorder
Interventions:   Drug: Short Acting Methylphenidate;   Drug: Long Acting Methylphenidate
Sponsor:   BRC Operations Pty. Ltd.
Recruiting - verified July 2016


Treatment of Prisoners With Attention Deficit Hyperactive Disorder in Trondheim Prison


Condition:   Attention Deficit Hyperactivity Disorder
Intervention:   Drug: Strattera
Sponsor:   Norwegian University of Science and Technology
Completed - verified April 2017


Johnston County ADHD Study: Environmental, Reporductive, and Familial Risk Factors for Attention-Deficit Hyperactivity Disorder (ADHD)


Condition:   Attention-Deficit Hyperactivity Disorder
Intervention:  
Sponsor:   National Institute of Environmental Health Sciences (NIEHS)
Completed - verified May 24, 2007


Strongest Families (Formerly Family Help Program): Pediatric Attention Deficit/Hyperactivity Disorder


Condition:   Attention Deficit/Hyperactivity Disorder
Interventions:   Behavioral: FHPADHD;   Behavioral: ADHD Standard Care
Sponsors:   IWK Health Centre;   Canadian Institutes of Health Research (CIHR)
Completed - verified March 2017


Treatment of Patients With Alcoholism and Attention Deficit Disorder


Conditions:   Alcoholism;   Attention Deficit Disorder
Intervention:   Drug: Methylphenidate
Sponsor:   National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Completed - verified April 9, 2007


Genetic Analysis of Attention Deficit Hyperactivity Disorder (ADHD)


Condition:   Attention Deficit Disorder With Hyperactivity
Intervention:  
Sponsor:   National Human Genome Research Institute (NHGRI)
Completed - verified January 30, 2017

Refine Your Search Advanced Search